Imagilin Technology
Imagilin Technology is a Frederick, Maryland biotech company that develops and sells patented plant-based PA5051 probiotic nutraceutical supplements for human and animal health via DTC, retail, veterinary, and international distributor channels across North America and Asia.
- Company typePrivate
- Founded2003
- HeadquartersFrederick, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Imagilin Technology does
Imagilin Technology, LLC is a Frederick, Maryland-based biotechnology company founded in 2003 that develops and commercializes proprietary plant-based probiotic nutraceuticals for human and animal health. Structured as a privately held LLC with 1-10 employees, the company operates across the United States, Canada, Japan, China, Hong Kong, Taiwan, and Thailand through a combination of direct-to-consumer e-commerce, Amazon, retail, veterinary, and distributor channels. The company holds 8 issued patents and a Health Canada Natural Product Number (NPN 80095739) for its core ingredient.
The company's core technology is PA5051®, a patented strain of Pediococcus acidilactici (NRRL B-50517) isolated from plants using conventional microbial assays. Imagilin claims differentiating stability properties for this strain — heat resistance up to 185°F, stomach acid survival at pH 1.5, oxygen tolerance, and compatibility with antibiotic treatments — that together enable a 2-year room-temperature shelf life without refrigeration. The product portfolio is broad: NutriLots and Nutri-5051 for human digestive and immune health (capsule, veggie, cranberry, replenish, and freeze-dried snack formats), MitoMax for companion animals (dogs and cats) in digestive, joint, urinary, electrolyte, jerky treat, and freeze-dried treat variants, MitoHorse for equines, and niche products for birds, fish, swine, small mammals, and reptiles (MITOCRITTER, MITOREPTO). Several products also incorporate Saccharomyces boulardii as a complementary yeast probiotic.
Imagilin generates revenue through one-time sales of finished branded products and bulk sales of PA5051 / Nutri-5051 / Mito-5051 ingredient powder to other companies for use in food and pet food applications (OEM/white-label channel). Distribution combines direct e-commerce on the company's own storefront, Amazon Marketplace, physical retail (The Common Market), veterinary clinics, and named international distributors (Apex Ingredients in Canada, Health Vision-Kyoritsu Seiyaku in Japan, An Jiashang in China, Evergrow Health Supplies in Hong Kong, Hong Chi Pet Products in Taiwan, and DKSH Limited in Thailand). Pricing is not publicly disclosed and operates on a quote-based B2B and standard B2C retail basis. The company is actively recruiting additional qualified distributors in Latin America, Europe, the Middle East, and additional Asian markets.
Imagilin Technology firmographics
Firmographics- Name
- Imagilin Technology
- Legal name
- Imagilin Technology, LLC
- Website
- https://imagilin.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Imagilin Technology is a Frederick, Maryland biotech company that develops and sells patented plant-based PA5051 probiotic nutraceutical supplements for human and animal health via DTC, retail, veterinary, and international distributor channels across North America and Asia.
- Ownership category
- akta.pro rank
Imagilin Technology industry classification
Industry- Product category
- Probiotic Nutraceuticals
- NAICS
- Animal Food Manufacturing (31111), Dog and Cat Food Manufacturing (311111), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Miscellaneous Food Preparations & Kindred Products (2090), Agricultural Prod-Livestock & Animal Specialties (200)
- akta.pro primary industry
- Nutraceuticals & Functional Ingredients for Animal Diets (Probiotics, Omega-3, Joint, GI) (HLAMAHAH)
- akta.pro secondary industries
- Non-Antibiotic Health & Performance Supplements (Immune, Gut Health, Stress/Heat Support) (AFADALAO), Digestive & Gut Health (Probiotics/Prebiotics/Enzymes) (HLAMALAC), Probiotics (Strains, Spore-Formers, Synbiotic Components) (AFAJAKAE), Probiotics (Human & Animal Strains, Spore-Formers, Synbiotic Bases) (AFAJAJAE), Probiotics, Prebiotics & Synbiotics (AFADAKAC)
Keywords
Where Imagilin Technology is headquartered
LocationHeadquarters
- HQ city
- Frederick
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Imagilin Technology business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Nutraceutical Product Sales: Imagilin generates revenue through selling proprietary probiotic supplements for human and animal health. Product lines include NutriLots for humans, MitoMax/Mito-5051 for companion animals, MitoHorse for equines, and specialty products for birds, fish, and swine. Products are sold as finished goods and as ingredients (powder form) to other companies.
Go-to-market motion3 records
Distribution channels6 records
Marketing channels4 records
Imagilin Technology product offering
Product offeringCore offering
Imagilin Technology develops and sells patented plant-based probiotic (PA5051) nutraceutical products for both human and animal health. The product portfolio includes finished consumer supplements and treats under brands like NutriLots (humans), MitoMax (dogs/cats), MitoHorse (equines), MitoBird/MitoFish/MitoSwine/MITOCRITTER/MITOREPTO (other animals), plus bulk probiotic ingredients (Nutri-5051 and Mito-5051) sold to other companies for food and pet food applications.
Product overview
Imagilin Technology is a biotechnology company (founded 2003) that develops and produces novel nutraceutical products based on patented plant-based probiotic technology. The core technology is PA5051® (Pediococcus acidilactici NRRL B-50517), a patented probiotic ingredient isolated from plants that exhibits stability at high temperatures, stomach acids, and oxygen exposure. The product portfolio spans human and animal health segments: For humans, the NutriLots™ brand offers probiotic supplements in various forms (capsules, freeze-dried snacks) and the Nutri-5051® ingredient for food applications. For companion animals (dogs & cats), the MitoMax® brand includes products for digestive health (DH), joint health (JH), urinary health (UH), veterinary strength (SUPER), and treat formats (dehydrated jerky, freeze-dried apples). For equines, MitoHorse® provides digestive and immune support. For other animals, products include MitoBird™ (birds), MitoFish™ (fish), MitoSwine™ (swine), MITOCRITTER™ (small animals), and MITOREPTO™ (reptiles). The company also offers Saccharomyces boulardii as a complementary probiotic yeast in various formulations. All products leverage the PA5051® technology platform, enabling shelf stability of up to 2 years without refrigeration and compatibility with antibiotic treatments.
Differentiator
Problem solved
Functional benefit
Brands
- NutriLots: Premium plant-based probiotic supplements for human consumption, including standard, Veggie, Cranberry, Replenish, and Freeze-Dried variants
- MitoMax
- MitoHorse
- MitoBird
- MitoFish
- MitoSwine
- Mito-5051
- Nutri-5051
- MITOCRITTER
- MITOREPTO
- ELECTROLYTES
- MitoProbiotics
Products and services
- PA5051® Patented plant-based probiotic ingredient (Pediococcus acidilactici NRRL B-50517) that serves as the foundation technology across all human and animal product lines. Exhibits stability at stomach acids, high temperatures up to 185°F, and oxygen exposure, enabling 2-year shelf stability without refrigeration.
- Nutri-5051®
- Mito-5051® Premium plant-based probiotic supplement and ingredient for animals made with PA5051®, providing 5 billion CFU guaranteed at time of consumption. Stable at room temperature for 2 years and survives temperatures up to 185°F. Sold as a bulk ingredient for animal food applications.
- NutriLots™ Premium plant-based probiotic supplement line for humans made with PA5051® (5051®), supporting digestion and immune responses. Available in standard, Veggie, Cranberry, Replenish, and Freeze-Dried (Apple, Banana) variants for individual consumers seeking digestive and immune health support.
- MitoMax® Plant-based probiotic supplement line for dogs and cats made with patented Mito-5051® probiotic. Includes MitoMax DH (digestive health with Saccharomyces boulardii), MitoMax JH (hip and joint support with glucosamine and hyaluronic acid), MitoMax UH (urinary health with cranberry), MitoMax SUPER (veterinary strength), DH DJ (dehydrated jerky treats), DH FD (freeze-dried apple treats), MITOCAT Powder, and ELECTROLYTES (electrolyte supplement with probiotics).
- MitoHorse® Premium plant-based probiotic for horses featuring Mito-5051® and Saccharomyces boulardii for digestive and immune support. Provides 1 billion live probiotics per 100 lbs body weight.
- MitoBird™ Plant-based probiotic supplement for birds with Mito-5051® and mannanoligosaccharides (MOS prebiotic) for digestive and immune health. Available in standard and powder forms for year-round use.
- MitoFish™ Probiotic supplement for ornamental fish combining Mito-5051® and mannanoligosaccharides to support digestive health during travel and everyday wellness. Available in standard and powder forms.
- MitoSwine™ Probiotic supplement combining Mito-5051® and Saccharomyces boulardii for digestive and immune function in pigs. Delivers 1 billion live probiotics with 2-year shelf life.
- MITOCRITTER™ Powder Plant-based probiotic powder for small companion animals (rabbits, guinea pigs, hamsters, etc.) with Mito-5051® for digestive and immune health.
- MITOREPTO™ Powder Plant-based probiotic powder for reptiles and amphibians with Mito-5051® for digestive and immune health.
- Saccharomyces boulardii Probiotic yeast strain used alongside PA5051® in various product formulations. Clinically proven to prevent antibiotic-caused diarrhea and supports gastrointestinal tract function.
Quantifiable outcome
- PA5051 survived in pH 1.5 acidic environment while Lactobacillus acidophilus multi-strain showed significantly lower survival rates
- +2 more outcomes
Companies that use Imagilin Technology
Customer profileSegments4 records
Ideal customer profiles4 records
Imagilin Technology technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Imagilin Technology partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core.
- Apex IngredientscoreCanadian distributor for Imagilin products, enabling market access in Canada for human and animal probiotic supplements.
- Health Vision - Kyoritsu SeiyakucoreJapanese distributor partnership for Imagilin probiotic products in the Japan market.
- An JiashangcoreChinese distribution partner for Imagilin products, facilitating market entry in China.
- Evergrow Health SuppliescoreHong Kong distributor for Imagilin probiotic supplements.
- Hong Chi Pet Products Imageling Co., Ltd.coreTaiwan distribution partner specializing in pet products for Imagilin.
- DKSH Limited (Thailand)coreRegional distributor in Thailand for Imagilin probiotic products.
Scale indicators3 records
Recent moves9 records
Expansion highlights5 records
Imagilin Technology competitors and assessment
Company assessmentDirect peers
- Probi AB: Swedish probiotic R&D company that develops and licenses probiotic bacterial strains for food supplements and functional foods. Comparable to Imagilin in being a probiotic IP/strain platform with B2B licensing and finished-product arms.
- Orffa Animal Nutrition: European specialty feed additive and ingredient distributor with probiotic offerings for companion animals and livestock. Comparable niche positioning to Imagilin in animal probiotics, particularly equine and pet segments.
- Nutramax Laboratories: U.S. manufacturer of branded joint, digestive, and urinary health supplements for companion animals (Cosequin, Proviable, etc.). Closely comparable to Imagilin's MitoMax DH/JH/UH pet supplement portfolio in target market and channel mix (vet and specialty retail).
- Lallemand: Canadian-founded global yeast and bacteria specialist producing probiotic strains for human nutrition, animal nutrition, and aquaculture. Highly comparable to Imagilin's PA5051 ingredient business and animal product lines across horses, swine, and aquaculture.
- BioGaia: Swedish probiotic company that develops and markets clinically proven probiotic products for both human and animal health (including infants and pets). Closely comparable to Imagilin in product strategy, focus on documented probiotic strains, and dual human/animal positioning.
- Kemin Industries: Global ingredient manufacturer providing gut health, immune, and stress solutions for both human and animal nutrition markets. Direct overlap with Imagilin's MitoMax and Mito-5051 animal supplement lines.
Broad incumbents
- ADM Animal Nutrition: Global agribusiness with a large animal nutrition division offering probiotics, prebiotics, and feed additives for livestock, pets, and aquaculture. Competes with Imagilin's MitoSwine, MitoFish, and Mito-5051 ingredient products.
- Evonik (GutCare): Global specialty chemicals company with an animal nutrition business offering GutCare probiotic strains for poultry and swine. Directly competes with Imagilin's PA5051 ingredient for animal feed applications.
- Novonesis (Chr. Hansen): Global bioscience giant formed by the merger of Novozymes and Chr. Hansen, the world's largest producer of probiotic bacterial cultures for food, supplements, and animal health. Directly competes with Imagilin across human and animal probiotic ingredients but operates at vastly greater scale and breadth.
- Kerry Group (GanedenBC30): Global taste and nutrition company whose GanedenBC30 probiotic ingredient competes directly with PA5051 in B2B food and beverage applications. Offers comparable heat-stable probiotic ingredients for food processing.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Imagilin Technology social profiles
Digital presenceImagilin Technology compliance and trust
Trust signalCompliance1 record
Imagilin Technology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Imagilin Technology leadership team
Management profileNumber of profiles
Imagilin Technology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Imagilin Technology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Imagilin Technology
What does Imagilin Technology do?
Imagilin Technology develops and sells patented plant-based probiotic (PA5051) nutraceutical products for both human and animal health. The product portfolio includes finished consumer supplements and treats under brands like NutriLots (humans), MitoMax (dogs/cats), MitoHorse (equines), MitoBird/MitoFish/MitoSwine/MITOCRITTER/MITOREPTO (other animals), plus bulk probiotic ingredients (Nutri-5051 and Mito-5051) sold to other companies for food and pet food applications.
Is Imagilin Technology a public or private company?
Imagilin Technology is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Imagilin Technology founded?
Imagilin Technology was founded in 2003. It employs 1 to 10 people.
Where is Imagilin Technology based?
Imagilin Technology is headquartered in Frederick, United States, in the North America region.
How does Imagilin Technology make money?
One revenue line is on record: nutraceutical Product Sales.
Who are Imagilin Technology's main competitors?
Direct peers on record are Probi AB, Orffa Animal Nutrition, Nutramax Laboratories, Lallemand, BioGaia and Kemin Industries. Broad incumbents are ADM Animal Nutrition, Evonik (GutCare), Novonesis (Chr. Hansen) and Kerry Group (GanedenBC30).
Does Imagilin Technology have an API?
No public API is recorded for Imagilin Technology.
What industry is Imagilin Technology in?
Imagilin Technology's product category is Probiotic Nutraceuticals. Its primary akta.pro industry code is HLAMAHAH, Nutraceuticals & Functional Ingredients for Animal Diets (Probiotics, Omega-3, Joint, GI), with a secondary code of AFADALAO, Non-Antibiotic Health & Performance Supplements (Immune, Gut Health, Stress/Heat Support). Its NAICS code is 31111 and its SIC code is 2833.